Supplementary Web references for Position Paper, O’Brien et al.
1w.
Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring: use in
hypertension research and clinical practice. Hypertension 1993;21:500–524.
2w.
Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant FC, Kaczorowski J.
Conventional versus automated measurement of blood pressure in primary care
patients with systolic hypertension: randomized parallel design controlled trial.
BMJ 2011;342:d286.
3w.
Campbell NRC, McKay DW, Conradson H, Lonn E, Title LM, Anderson T. Automated
oscillometric blood pressure versus auscultatory blood pressure as a predictor of
carotid intima-medial thickness in male fire-fighters. J Human Hypertens
2007;21:588-590.
4w.
Andreadis EA, Agaliotis GD, Angelopoulos ET, Tsakanikas AP, Chaveles IA,
Mousoulis GP. Automated office blood pressure and 24-h ambulatory
measurements are equally associated with left ventricular mass index. Am J
Hypertens 2011;24:661-666.
5w.
Myers MG, Oh P, Reeves RA, Joyner CD. Prevalence of white coat effect in treated
hypertensive patients in the community. Am J Hypertens 1995;8:591-597.
6w.
Logan AG. Ambulatory blood pressure monitoring: its time to move on! J
Hypertens 2010;28:2000–2.
7w.
O’Brien E. Is the case for ABPM as a routine investigation in clinical practice not
overwhelming? Hypertension 2007;50:284–6.
8w.
Staessen JA, O’Brien ET, Thijs L, Fagard R. Modern approaches to blood pressure
measurement. Occup Environ Med 2000;57:510-520.
9w.
Pickering T, O’Brien E, O’Malley K. Second international consensus meeting on
twenty-four-hour ambulatory blood pressure measurement:consensus and
conclusions. J Hypertens 1991;9(suppl 8):S2–S6.
1
10w.
O’Brien E, Beevers G, Lip GHY. ABC of hypertension. Part III. Automated
sphygmomanometry: ambulatory blood pressure measurement. BMJ
2001;322:1110–1114.
11w.
O’Brien E. Ambulatory blood pressure monitoring in the management of
hypertension. Heart 2003;89:571-6.
12w.
Pickering T, for the American Society of Hypertension Ad Hoc Panel.
Recommendations for the use of home (self) and ambulatory blood pressure
monitoring. Am J Hypertens 1996;9:1–11.
13w.
Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A. Ambulatory blood
pressure monitoring in clinical trials. J Hypertens Suppl 1991;9:S13-9.
14w.
O’Brien E, Staessen J. Normotension and hypertension as defined by 24-hour
ambulatory blood pressure monitoring. Blood Pressure 1995;4:266–282.
15w.
Mancia G, O’Brien E, Imai Y, Redon J. Task Force II: ambulatory blood pressure
monitoring in population studies. Blood Press Monit 1999;4:295–301.
16w.
Mancia G, Sega R, Grassi G, Cesana G, Zanchetti A. Defining ambulatory and home
blood pressure variability. Further considerations from PAMELA study. J Hypertens
2001;19:995–999.
17w.
Verdecchia P, Staessen JA, White WB, Imai Y, O’Brien ET. Properly defining white
coat hypertension. Eur Heart J 2002;23:106-109.
18w.
Mancia G, Parati G. Guiding antihypertensive treatment decisions using
ambulatory blood pressure monitoring. Curr Hypertens Rep 2006;8:330-337.
19w.
Parati G, Valentini M. Do we need out-of-office blood pressure in every patient?
Curr Opin Cardiol 2007;22:321–328.
20w.
Ramsey SD, Neil N, Sullivan SD, Perfetto E. An economic evaluation of the JNC
hypertension guidelines using data from a randomized controlled trial. Joint
National Committee. J Am Board Fam Pract 1999;12:105–114.
2
21w.
White WB. Expanding the use of ambulatory blood pressure monitoring for the
diagnosis and management of patients with hypertension. Hypertension
2006;47:14-15.
22w.
Stergiou GS, Karpettas N, Atkins N, O'Brien E. European Society of Hypertension
International Protocol for the validation of blood pressure monitors: a critical
review of its application and rationale for revision. Blood Press Monit 2010;15:3948.
23w.
Stergiou GS, Karpettas N, Atkins N, O'Brien E. Impact of applying the more
stringent validation criteria of the revised European Society of Hypertension
International Protocol 2010 on earlier validation studies. Blood Press Monit
2011;16:67-73.
24w.
Stergiou GS, Karpettas N, Atkins N, O’Brien E. The European Society of
Hypertension International Protocol for the validation of blood pressure measuring
devices in adults. Response to--Blood Pressure Monitoring 2011;16: 67-73. Blood
Press Monit 2012;17:45-47.
25w.
Atkins N, Stergiou GS, O’Brien E. European Society of Hypertension International
Protocol for the Validation of Blood Pressure Measuring Devices: Statistical Basis
for Subject Selection and Sample Size. Blood Press Monit 2013 [In press].
26w.
Masiero S, Fania C, Palatini P. Validation of the UEBE Visomat Double Comfort
upper arm blood pressure monitor, in auscultation mode, for clinic use and self
measurement in a general population, according to the European Society of
Hypertension International Protocol revision 2010. Blood Press Monit
2011;16:262-4.
27w.
O'Brien E, Stergiou GS. Who will bell the cat? A call for a new approach for
validating blood pressure measuring devices. J Hypertens 2010;28:2378–2381.
3
28w.
Association for the Advancement of Medical Instrumentation. American national
standard. Electronic or automated sphygmomanometers. Arlington, VA: AAMI;
1993.
29w.
http://www.dableducational.org/sphygmomanometers/devices_3_abpm.html#Ab
pmTable
30w.
O’Brien E, Atkins N. Staessen J. Factors influencing validation of ambulatory blood
pressure measuring devices. J Hypertens 1995;13:1235-1240.
31w.
Belsha CW, Wells TG, Rice HB, Neaville WA, Berry PL. Accuracy of the SpaceLabs
90207 ambulatory blood pressure monitor in children and adolescents. Blood Press
Monit 1996;1:127-133.
32w.
O’Sullivan J, Derrick G, Griggs P, Wren C. Validation of the Takeda 2421 ambulatory
blood pressure monitor in children. J Med Eng Technol 1998;22:101-105.
33w.
Alpert BS. Validation of Tiba Medical Ambulo 2400 blood pressure monitor to ISO
standard and BHS protocol. Blood Press Monit 2010;15:275-277.
34w.
Jones DP, Richey PA, Alpert BS. Validation of the AM5600 ambulatory blood
pressure monitor in children and adolescents. Blood Press Monit 2008;13:349-351.
35w.
Gilman M, Cook N. Blood pressure measurement in children epidemiological
studies. Circulation 1995 92:1049-1057.
36w.
Franx A, van der Post JAM, van Montfrans GA, Bruinse HW. Comparison of an
auscultatory versus an oscillometric ambulatory blood pressure monitor in
normotensive, hypertensive and preeclamptic pregnancy. Hypertension in
pregnancy 1997;16:187-202.
37w.
O'Brien E, Mee F, Atkins N, Halligan A, O'Malley K. Accuracy of the SpaceLabs
90207 ambulatory blood pressure measuring system in normotensive pregnant
women determined by the British Hypertension Society Protocol. J Hypertens
1993;11(suppl 5):S282-S283.
4
38w.
Shennan AH, Kissane J, de Swiet M. Validation of the SpaceLabs 90207 ambulatory
blood pressure monitor for use in pregnancy. Br J Obstet Gynaecol 1993;100:9048.
39w.
Shennan A, Halligan A, Gupta M, Taylor D, de Swiet M. Oscillometric blood
pressure measurements in severe preeclampsia: validation of the SpaceLabs
90207.Br J Obstet Gynaecol 1996;103:171-3.
40w.
Taylor DJ The epidemiology of hypertension during pregnancy Handbook of
hypertension Vol. 10. Hypertension in Pregnancy edited by Rubin PC Amsterdam
Elsevier 1988 pp:223-240
41w.
http://www.nhlbi.nih.gov/health/public/heart/hbp/hbp_preg.htm
42w.
Iqbal P, Fotherby MD, Potter JF. Validation of the SpaceLabs 90207 automatic noninvasive blood pressure monitor in elderly subjects. Blood Press Monit 1996;1:367373
43w.
Peixoto AJ, Gray TA, Crowley ST. Validation of the SpaceLabs 90207 Ambulatory
blood pressure device for hemodialysis patients. Blood Press Monit 1999;4:217–
221.
44w.
Fagugli RM, Vecchi L, Valente F, Santiros P, Laviola M. Comparison between
oscillometric and auscultatory methods of ambulatory blood pressure
measurement in hemodialysis patients. Clin Nephrol 2002;57:283–2.
45w.
Stergiou GS, Tzamouranis D, Nasothimiou EG, Karpettas N, Protogerou A. Are there
really differences between home and daytime ambulatory blood pressure?
Comparison using a novel dual-mode ambulatory and home monitor. J Hum
Hypertens 2010;24:207-12.
46w.
Ragazzo F, Saladini F, Palatini P. Validation of the Microlife WatchBP O3 device for
clinic, home, and ambulatory blood pressure measurement, according to the
International Protocol. Blood Press Monit 2010;15:59-62.
5
47w.
Uen S, Un I, Fimmers R, Vetter H, Mengden T. Myocardial ischemia during everyday
life in patients with arterial hypertension: prevalence, risk factors, triggering
mechanism and circadian variability. Blood Press Monit 2006;11:173-82.
48w.
Olsen R, Amlie A, Omvik P. Twenty-four-hour ambulatory blood pressure
monitoring in atrial fibrillation. Blood Press Monit 2002;7:149-156.
49w.
Roche F, Gaspoz JM, Court-Fortune I, Minini P, Pichot V, Duverney D et al.
Screening of obstructive sleep apnea syndrome by heart rate variability analysis.
Circulation 1999;111:1411-1415.
50w.
Roche F, Sforza E, Duverney D, Borderies JR, Pichot V, Bigaignon O et al. Heart rate
increment: an electrocardiological approach for the early detection of obstructive
sleep apnoea-hypopnea syndrome. Clin Sci (Lond).2004;107:105-110.
51w.
Baulmann J, Schillings U, Rickert S, Uen S, Düsing R, Illyes M et al. A new
oscillometric method for assessment of arterial stiffness: comparison with
tonometric and piezo-electronic methods. J Hypertens 2008;26:523–528.
52w.
Trachet B, Reymond P, Kips J, Swillens A, De Buyzere M, Suys B et al. Numerical
validation of a new method to assess aortic pulse wave velocity from a single
recording of a brachial artery waveform with an occluding cuff. Ann Biomed Eng
2010; 38:876-888.
53w.
Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P et al. Invasive
validation of a new oscillometric device (Arteriograph) for measuring
augmentation index, central blood pressure and aortic pulse wave velocity. J
Hypertens 2010;28:2068–2075.
54w.
Franssen P, Imholz B. Evaluation of the Mobil-O-Graph new generation ABPM
device using the ESH Criteria. Blood Press Monit 2010; 15:229-231.
6
55w.
Weiss W, Gohlisch C, Harsch-Gladisch C, Tölle M, Zidek W, van der Giet M.
Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph
in comparison with the SphygmoCor device. Blood Press Monit 2012;17:128-31.
56w.
Peixoto Filho AJ, Mansoor GA, White WB. Effects of actual versus arbitrary awake
and sleep times on analyses of 24-h blood pressure. Am J Hypertens 1995;8:67680.
57w.
Wetzler ML,Borderies JR,Bigaignon O,Guillo P,Gosse P. Validation of a two-axis
accelerometer for monitoring patient activity during blood pressure or ECG holter
monitoring. Blood Press Monit 2003;8:229-35.
58w.
Nair D, Tan SY, Gan HW, Lim SF, Tan J, Zhu M et al. The use of ambulatory
tonometric radial arterial wave capture to measure ambulatory blood pressure:
the validation of a novel wrist-bound device in adults. J Hum Hypertens
2008;22:220-222.
59w.
Boutouyrie P, Revera M, Parati G. Obtaining arterial stiffness indices from simple
arm cuff measurements: the holy grail? J Hypertension 2009;27:2159-2161.
60w.
Jatoi NA,Mahmud A,Bennett K,Feely J. Assessment of arterial stiffness in
hypertension: comparison of oscillometric (Arteriograph), piezoelectronic
(Complior) and tonometric (SphygmoCor) techniques. J Hypertens 2009;27:21862191.
61w.
Luzardo L, Lujambio I, Sottolano M, da Rosa A, Thijs L, Noboa O et al. 24-h
ambulatory recording of aortic pulse wave velocity and central systolic
augmentation: a feasibility study. Hypertens Res. 2012;35:980-7.
62w.
Rossen NB, Hansen KW. A plea for consistent reliability in ambulatory blood
pressure monitoring: an unusual case of software error in Spacelabs Report
Management System 92506. Blood Press Monit. 2013;18:27-31.
7
63w.
Dolan E, O’Brien E. Blood pressure variability: clarity for clinical practice.
Hypertension 2010;56:179–81.
64w.
Falqui V, Viazzi F, Leoncini G, Ratto E, Parodi A, Conti N, Tomolillo C, Deferrari G,
Pontremoli R. Blood pressure load, vascular permeability and target organ damage
in primary hypertension. J Nephrol. 2007;20 Suppl 12:S63-7.
65w.
Kennedy SE, Mackie FE, Craig E, Kainer G. The choice of threshold limits for
pediatric ambulatory blood pressure monitoring influences clinical decisions. Blood
Press Monit 2006;11:119-23.
66w.
Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure
product as an index of myocardial oxygen consumption during exercise in patients
with angina pectoris. Circulation 1978;57:549-56.
67w.
Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Li Y, Dolan E, Thijs L et al.
Ambulatory arterial stiffness index predicts stroke in a general population. J
Hypertens 2006;24:2247–2253.
68w.
Bastos JM, Bertoquini S, Polónia J. Prognostic significance of ambulatory arterial
stiffness index in hypertensives followed for 8.2 years: its relation with new events
and cardiovascular risk estimation. Rev Port Cardiol 2010;29:1287-303.
69w.
Muxfeldt ES, Cardoso CR, Dias VB, Nascimento AC, Salles GF. Prognostic impact of
the ambulatory arterial stiffness index in resistant hypertension. J Hypertens
2010;28:1547-53.
70w.
Robles NR, Mena C, Macias R, Garcia de Vinuesa E, Herrera J, Macias JF.
Symmetrical ambulatory arterial stiffness index: relationship with
microalbuminuria and renal function. Eur J Intern Med. 2010;21:118-22.
71w.
Dechering DG, van der Steen MS, Adiyaman A, Thijs L, Deinum J, Li Y, Dolan E et al.
Reproducibility of the ambulatory arterial stiffness index in hypertensive patients.
J. Hypertens 2008;26:1993-2000.
8
72w.
Stergiou GS, Kollias A, Rarra VC, Roussias LG. Ambulatory arterial stiffness index:
reproducibility of different definitions. Am J Hypertens 2010;23:129-34.
73w.
Ben-Dov IZ, Gavish B, Kark JD, Mekler J, Bursztyn M. A modified ambulatory arterial
stiffness index is independently associated with all-cause mortality. J Hum
Hypertens 2008;22:761-6.
74w.
Gavish B, Ben-Dov IZ, Kark JD, Mekler J, Bursztyn M. The association of a simple
blood pressure-independent parameter derived from ambulatory blood pressure
variability with short-term mortality. Hypertens Res 2009;32:488-95.
75w.
Rizzoni D, Muiesan ML, Salvetti M, Castellano M, Bettoni G, Monteduro C, et al.
The smoothness index, but not the trough-to-peak ratio predicts changes in carotid
artery wall thickness during antihypertensive treatment. J Hypertens 2001;19:703–
711.
76w.
Pickering T, Pieper C. Methods of analysis of ambulatory blood pressure data. In
Pickering TG. Ambulatory Monitoring and blood pressure variability. Science Press:
London 1991. Pp 16.1-16.15
77w.
Stergiou GS, Malakos JS, Zourbaki AS, Achimastos AD, Mountokalakis TD. Blood
pressure during siesta: effect on 24-h ambulatory blood pressure profiles analysis. J
Hum Hypertens 1997;11:125-131.
78w.
Fagard R, Staessen J, Thijs L. Optimal definition of daytime and nighttime blood
pressure. Blood Press Monit 1997;2:315–321.
79w.
Berardi L, Chau NP, Chanudet X, Vilar J, Larroque P. Ambulatory blood pressure
monitoring: a critical review of the current methods to handle outliers. J Hypertens
1992;10:1243–1248.
80w.
Casadei R, Parati G, Pomidossi G, Groppelli A, Trazzi S, Di Rienzo M, Mancia G. 24hour blood pressure monitoring: evaluation of Spacelabs 5300 monitor by
9
comparison with intra-arterial recording in ambulant subjects. J Hypertens
1988;6:797–803.
81w.
Palatini P, Parati G. blood pressure measurement in very obese patients: a
challenging problem. J Hypertens 2011;29:425-9.
82w.
Maxwell GF, Pruijt JF, Arntzenius AC. Comparison of the conical cuff and the
standard rectangular cuffs. Int J Epidemiol 1985;14:468-72.
83w.
Palatini P, Benetti E, Fania C, Malipiero G, Saladini F. Rectangular cuffs may
overestimate blood pressure in individuals with large conical arms. J Hypertens
2012;30:530-6.
84w.
Stergiou GS, Tzamouranis D, Nasothimiou EG, Protogerou AD. Can an electronic
device with a single cuff be accurate in a wide range of arm size? Validation of the
Visomat Comfort 20/40 device for home blood pressure monitoring. J Hum
Hypertens 2008;22:796-800.
85w.
Bonso E, Dorigatti F, Saladini F, Palatini P. Validation of the Visomat Comfort form
device for home blood pressure measurement according to the International
Protocol. Blood Press Monit 2010;15:63-6.
86w.
Bonso E, Dorigatti F, Palatini P. Accuracy of the blood pressure A100 blood
pressure measuring device coupled with a single cuff with standard-size bladder
over a wide range of arm circumferences. Blood Press Monit 2009;14:216-9.
87w.
Masiero S, Saladini F, Benetti E, Palatini P. Accuracy of the Microlife large-extra
large-sized cuff (32-52 cm) coupled to an automatic oscillometric device. Blood
Press Monit 201;16:99-102.
88w.
Alpert BS. Validation of the Welch Allyn Sure blood pressure (inflation) and Step
blood pressure (deflation) algorithms by AAMI standard testing and BHS data
analysis. Blood Press Monit 2011;16:96-8.
10
89w.
Emerick DR. An evaluation of non-invasive blood pressure (NI blood pressure)
monitoring on the wrist: Comparison with upper arm NI blood pressure
measurement. Anaesth Intensive Care 2002;30:43-7.
90w.
Singer AJ, Kahn SR, Thode HC Jr, Hollander JE. Comparison of forearm and upper
arm blood pressures. Prehosp Emerg Care 1999;3:123-6.
91w.
Pierin AMG, Alavarce DC, Gusmao JL, Halpern A, Mion D. Blood pressure
measurement in obese patients: comparison between upper arm and forearm
measurements. Blood Press Monit 2004;9:101-5.
92w.
Palatini P, Longo D, Toffanin G, Bertolo O, Zaetta V, Pessina AC. Wrist blood
pressure overestimates blood pressure measured at the upper arm. Blood Press
Monit 2004;9:77-81.
93w.
Domiano KL, Hinck SM, Savinske DL, Hope KL. Comparison of upper arm and
forearm blood pressure. Clin Nurs Res 2008;17:241-50.
94w.
O'Brien E. What to do when faced with an unmeasurable ambulatory blood
pressure? J Hypertens 2011;29:451-3.
95w.
Penaz J. Photo-electric measurement of blood pressure, volume and flow in the
finger. Dresden: digest of Tenth International Conference on Medical and
Biological Engineering. Dresden (Germany), August 13e17, 1973.
96w.
Hehenkamp WJ, Rang S, van Goudoever J, Bos WJ, Wolf H, van der Post JA.
Comparison of Portapres with standard sphygmomanometry in pregnancy.
Hypertens Pregnancy 2002;21:65-76.
97w.
Imholz BPM, Langewouters GW, Van Montfrans GA, Parati G, Van Goudoever J,
Wesseling KH et al. Feasibility of ambulatory, continuous 24-hour, finger arterial
pressure recording. Hypertension 1993;21:65-73.
11
98w.
Eckert S, Horstkotte D. Comparison of Portapres non-invasive blood pressure
measurement in the finger with intra-aortic pressure measurement during
incremental bicycle exercise. Blood Press Monit 2002;7:179-83.
99w.
Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS.
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.
JAMA 2003;289:76-9.
100w. Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ et al.; Sleep Heart
Health Study Research Group. Predictors of sleep-disordered breathing in
community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med
2002;162:893-900.
101w. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM,
Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of
Metabolic Risk Factors of Chronic Diseases Collaborating Group. National, regional,
and global trends in body-mass index since 1980: systematic analysis of health
examination surveys and epidemiological studies with 960 country-years and 9.1
million participants. Lancet 2011;377:557-67.
102w. Almeida L, Amado P, Vasconcelos N, Santos I, Alves J, Teles J et al. [Is ambulatory
blood pressure monitoring reliable in hypertensive
patients with atrial fibrillation?]. Rev Port Cardiol 2001;20:647-50.
103w. Stewart MJ, Gough K, Padfield PL. The accuracy of automated blood pressure
measuring devices in patients with controlled atrial fibrillation. J Hypertens
1995;13:297-300.
104w. Lip GYH, Zarifis J, Beevers M, Beevers DG. Ambulatory blood pressure monitoring
in atrial fibrillation. Am J Cardiol 1996;78:350-353.
105w. Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a
modified microlife blood pressure monitor. Am J Hypertens 2009;22:848-52.
12
106w. Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M. Diagnostic
accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum
Hypertens 2009;23:654-8.
107w. Marazzi G, Iellamo F, Volterrani M, Lombardo M, Pelliccia F, Righi D et al.
Comparison of Microlife BP A200 Plus and Omron M6 blood pressure monitors to
detect atrial fibrillation in hypertensive patients. Adv Ther 2012;29:64-70.
108w. Kleinert HD, Harshfield GA, Pickering TG, Devereux RB, Sullivan PA, Marion RM, et
al. What is the value of home blood pressure measurement in patients with mild
hypertension? Hypertension 1984;6:574-578.
109w. Owens P, Atkins N, O’Brien E. Diagnosis of white coat hypertension by ambulatory
blood pressure monitoring. Hypertension 1999;34:267–272.
110w. O’Brien E. Assessment of circadian cardiovascular risk with ambulatory blood
pressure measurement. In: Mancia G, ed. Manual of Hypertension of the European
Society of Hypertension. Abingdon, UK:Taylor and Francis, 2007,48–60.
111w. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K,
Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K,
Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K,
Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA; International Database on
Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators.
Significance of white-coat hypertension in older persons with isolated systolic
hypertension: a meta-analysis using the International Database on Ambulatory
Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population.
Hypertension 2012;59:564-71.
112w. Bjorklund K, Lind L, Vessby B, Andren B, Lithell H. Different metabolic predictors of
white-coat and sustained hypertension over a 20-year follow-up period: a
population-based study of elderly men. Circulation 2002;106:63-68.
13
113w. Parati G, Ulian L, Sampieri L, Palatini P, Villani A, Vanasia A, Mancia G, on behalf of
the Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation
(SAMPLE) Study Group. Attenuation of the ‘white coat effect’ by antihypertensive
treatment and its relationship to regression of target organ damage. Hypertension
2000;35:614–620.
114w. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R et al. Alterations of
cardiac structure in patients with isolated office, ambulatory, or home
hypertension: Data from the general population (Pressione Arteriose Monitorate E
Loro Associazioni [PAMELA] Study). Circulation 2001;104:1385-92.
115w. Owens PE, Lyons SP, Rodriguez SA, O’Brien ET. Is elevation of clinic blood pressure
in patients with white coat hypertension who have normal ABPM associated with
target organ changes? J Hum Hypertens 1998;12:743–748.
116w. Staessen JA, O’Brien ET, Atkins N, Amery AK, on behalf of the Ad-Hoc Working
Group. Short report: ABPM in normotensive compared with hypertensive subjects.
J Hypertens 1993;11:1289–1297.
117w. Sorof JM, Poffenbarger T, Franco K, Portman R. Evaluation of white-coat
hypertension in children: importance of the definitions of normal ambulatory
blood pressure and the severity of casual hypertension. Am J Hypertens
2001;14:855-860.
118w. Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC.
Independent predictors of isolated clinic (‘white-coat’) hypertension. J Hypertens
2001;19:1015-1020.
119w. Stabouli S, Kotsis V, Toumanidis S, Papamichael C, Constantopoulos A, Zakopoulos
N. White-coat and masked hypertension in children: association with target organ
damage. Pediatr Nephrol 2005;20:1151-1155.
14
120w. Parati G, Redon J. Direct and surrogate measures of the white-coat effect:
methodological aspects and clinical relevance. J Hypertens 2000;18:379–382.
121w. Palatini P, Palomba D, Bertolo O, Minghetti R, Longo D, Sarlo M, Pessina AC. The
white coat effect is unrelated to the difference between clinic and daytime blood
pressure and is associated with greater reactivity to public speaking. J Hypertens
2003;21:545-553.
122w. Myers MG, Reeves RA. White coat phenomenon in patients receiving
antihypertensive therapy. Am J Hypertens 1991;4:844-849.
123w. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R et al. Whitecoat hypertension and white-coat effect: similarities and differences. Am J
Hypertens 1995;8:790–798.
124w. Myers MG, Valdivieso M, Chessman M, Kiss A. Can sphygmomanometers designed
for self-measurement of blood pressure in the home be used in office practice?
Blood Press Monit 2010;15:300-304.
125w. Parati G , Pomidossi G, Casadei R, Mancia G. Lack of alerting reactions to
intermittent cuff inflations during non-invasive blood pressure monitoring.
Hypertension 1985;7:597-601.
126w. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction
and rise in blood pressure during measurement by physician and nurse.
Hypertension 1987;9:209-215.
127w. Fagard RH, Stolarz K, Kuznetsova T, Seilerova J, Tikhonoff V, Grodzicki T, Nikitin Y,
Filipovsky J, Peleska J, Casiglia E, Thijs L, Staessen JA, Kawecka-Jaszcz. Sympathetic
activity, assessed by power spectral analysis of heart rate variability, in white-coat,
masked and sustained hypertension versus true normotension. J Hypertens
2007;25:2280-2285.
15
128w. Kayrak M, Bacaksiz A, Vatankulu MA, Ayhan SS, Kaya Z, Ari H et al. Exaggerated
blood pressure response to exercise – a new portent of masked hypertension. Clin
Exp Hypertens 2010;32:560-568.
129w. Schultz MG, Hare JL, Marwick TH, Stowasser M, Sharman JE. Masked hypertension
is "unmasked" by low-intensity exercise blood pressure. Blood Press 2011;20:2849.
130w. O’Brien E. Unmasking hypertension. Hypertension 2005;45:481–2.
131w. Aksoy I, Deinum J, Lenders JW, Thien T. Does masked hypertension exist in healthy
volunteers and apparently well-controlled hypertensive patients? Neth J Med
2006; 64:72–77.
132w. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J et al. Prognosis of
"masked" hypertension and "white-coat" hypertension detected by 24-h
ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
J Am Coll Cardiol. 2005;46:508-515.
133w. Cuspidi C, Parati G. Masked hypertension: an independent predictor of organ
damage. J Hypertens 2007;25:275–279.
134w. Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen JA. Prevalence,
persistence, and clinical significance of masked hypertension in youth.
Hypertension 2005;45:493-8.
135w. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. In clinical practice, masked
hypertension is as common as isolated clinic hypertension: predominance of
younger men. Am J Hypertens 2005;18:589–593.
136w. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. The conventional
versus automated measurement of blood pressure in the office (CAMBO) trial:
masked hypertension sub-study. J Hypertens 2012;30:1937-41.
16
137w. Calvo C, Hermida RC, Ayala DE, López JE, Fernández JR, Domínguez MJ et al. The
‘ABPM effect’ gradually decreases but does not disappear in successive sessions of
ambulatory monitoring. J Hypertens 2003;21:2265–73.
138w. O’Brien E. Sleepers v non-sleepers: a new twist in the dipper/non-dipper concept.
Hypertension 2007;49:769–70.
139w. Bursztyn M, Mekler J, Wachtel N, Ben-Ishay D. Siesta and ambulatory blood
pressure monitoring. Comparability of the afternoon nap and night sleep. Am J
Hypertens 1994;7:217–21.
140w. Chonan K, Kikuya M, Araki T, Fujiwara T, Suzuki M, Michimata M et al. Device for
the self-measurement of blood pressure that can monitor blood pressure during
sleep. Blood Press Monit 2001;6:203-205.
141w. Stergiou GS, Nasothimiou EG, Destounis A, Poulidakis E, Evagelou I, Tzamouranis D.
Assessment of the diurnal blood pressure profile and detection of non-dippers
based on home or ambulatory monitoring. Am J Hypertens 2012;25:974-978.
142w. Stolarz K, Staessen JA, O'Brien ET. Night-time blood pressure: dipping into the
future? J Hypertens 2002;20:2131-3.
143w. Parati G. Blood pressure reduction at night: sleep and beyond. J Hypertens
2000;18:1725-1729.
144w. Parati G. Blood pressure fall at night: more than a single mechanism. J Hypertens
2001;19:1-2.
145w. Parati G, Staessen J. Day-night blood pressure variations: mechanisms,
reproducibility and clinical relevance. J Hypertens 2007;25:2377-2380.
146w. Bellelli G, Frisoni GB, Lucchi E, Guerini F, Geroldi C, Magnifico F et al. Blunted
reduction in nighttime blood pressure is associated with cognitive deterioration in
subjects with long-standing hypertension. Blood Press Monit 2004;9:71–6.
17
147w. Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. Association between
nocturnal blood pressure reduction and progression of visual field defect in
patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J
Ophthalmol 2004;48:380-5.
148w. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC.Hypertension, perfusion
pressure, and primary open-angle glaucoma. A population-based assessment. Arch
Ophthalmol 1995;113:216-221.
149w. Smirk FH. Observations on the mortality of 270 treated and 199 untreated retinal
grade I and II hypertensive patients followed in all instances for five years. N Z Med
J 1964;63:413-43.
150w. Rachmani R, Shenhav G, Slavachevsky I, Levy Z, Ravid M. Use of a mild sedative
helps to identify true non-dippers by ABPM: a study in patients with diabetes
mellitus and hypertension. Blood Press Monit 2004;9:65–9.
151w. Palatini P. Non-dipping in hypertension: still a challenging problem. J Hypertens
2004;22:2269–72.
152w. Ben-Dov IZ, Ben-Arieh L, Mekler J, Bursztyn M. Blood pressure dipping is
reproducible in clinical practice. Blood Press Monit 2005;10:79–84.
153w. Chaves H, Campellode Souza FM, Krieger EM. The reproducibility of dipping status:
beyond the cutoff points. Blood Press Monit 2005;10:201–5.
154w. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S et al. Ambulatory
blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality.
The Ohasama Study. Hypertension 2005;45:240–5.
155w. Mousa T, El-Sayed MA, Motawea AK, Salama MA, Elhendy A. Association of
blunted nighttime blood pressure dipping with coronary artery stenosis in men.
Am J Hypertens 2004;17:977–80.
18
156w. Cicconetti P, Morelli S, Ottaviani L, Chiarotti F, De Serra C, De Marzio P et al.
Blunted nocturnal fall in blood pressure and left ventricular mass in elderly
individuals with recently diagnosed isolated systolic hypertension. Am J Hypertens
2003;16:900–5.
157w. Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and
sodium sensitivity. Hypertension 2006;48:527–533.
158w. Coruzzi P, Parati G, Brambilla L, Brambilla V, Gualerzi M, Novarini A et al. Effects of
salt sensitivity on neural cardiovascular regulation in essential hypertension.
Hypertension 2005;46:1321-1326.
159w. Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S. Decline of renal function is
associated with proteinuria and systolic blood pressure in the morning in diabetic
nephropathy. Clin Exp Hypertens 2005;27:129-38.
160w. Marfella R, Siniscalchi M, Nappo F, Gualdiero P, Esposito K, Sasso FC et al.
Regression of carotid atherosclerosis by control of morning blood pressure peak in
newly diagnosed hypertensive patients. Am J Hypertens 2005;18:308–18.
161w. Pickering TG. Morning hypertension. J Clin Hypertens 2007;9:224-8.
162w. Asayama K, Ohkubo T, Kikuya M, Obara T, Metoki H, Inoue R et al. Prediction of
stroke by home morning versus evening blood pressure values: the Ohasama
study. Hypertension 2006;48:737-43.
163w. Stergiou GS, Nasothimiou EG, Roussias LG. Morning hypertension assessed by
home or ambulatory monitoring: different aspects of the same phenomenon? J
Hypertens 2010;28:1846-53.
164w. Stergiou GS, Mastorantonakis SE, Roussias LG. Morning blood pressure surge: the
reliability of different definitions. Hypertens Res 2008;31:1589-94.
19
165w. Stergiou G, Parati G. Further insights into the 24-h blood pressure profile by home
blood pressure monitoring: the issue of morning hypertension. J Hypertens
2009;27:696-699.
166w. Head GA, Chatzivlastou K, Lukoshkova EV, Jennings GL, Reid CM. A novel measure
of the power of the morning blood pressure surge from ambulatory blood pressure
recordings. Am J Hypertens 2010;23:1074-1081.
167w. Giles T. Relevance of blood pressure variation in the circadian onset of
cardiovascular events. J Hypertens 2005; 23(suppl 1):S35–9.
168w. Parati G, Di Rienzo M, Bonsignore MR, Insalaco G, Marrone O, Castiglioni P et al.
Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from
spontaneous baroreflex analysis during sleep. J Hypertens 1997;15:1621-1626.
169w. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, Kales A.
Association of hypertension and sleep-disordered breathing. Arch Intern Med
2000;160:2289-95.
170w. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and
related clinical features in a population-based sample of subjects aged 30 to 70 yr.
Am J Respir Crit Care Med 2001; 163:685-9.
171w. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and
hypertension. A population-based study. Ann Intern Med 1994;120:382-8.
172w. Tanigawa T, Tachibana N, Yamagishi K, Muraki I, Kudo M, Ohira T et al. Relationship
between sleep-disordered breathing and blood pressure levels in communitybased samples of Japanese men. Hypertens Res 2004;27:479-84.
173w. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. Populationbased study of sleep-disordered breathing as a risk factor for hypertension. Arch
Intern Med 1997;157:1746-52.
20
174w. O'Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S et al.
Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart
Health Study. Am J Respir Crit Care Med 2009;179:1159-64.
175w. Cano-Pumarega I, Durán-Cantolla J, Aizpuru F, Miranda-Serrano E, Rubio R,
Martínez-Null C et al. Obstructive sleep apnea and systemic hypertension:
longitudinal study in the general population: the vitoria sleep cohort. Am J Respir
Crit Care Med 2011;184:1299-304.
176w. Goff EA, O'Driscoll,DM, Simonds,AK, Trinder,J, Morrell,MJ. The cardiovascular
response to arousal from sleep decreases with age in healthy adults. Sleep 2008;
31:1009-17.
177w. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk
factor for uncontrolled hypertension. J Hypertens 2000; 18:679-85.
178w. Lavie P, Herer,P, Hoffstein,V. Obstructive sleep apnoea syndrome as a risk factor
for hypertension: population study. BMJ 2000;320:479-82.
179w. Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR. Case-control
study of 24 hour ambulatory blood pressure in patients with obstructive sleep
apnoea and normal matched control subjects. Thorax 2000;55:736-740.
180w. Hoffstein V. Is snoring dangerous to your health? Sleep 1996;19:506-16.
181w. Hu FB, Willett WC, Colditz GA, Ascherio A, Speizer FE, Rosner B et al. Prospective
study of snoring and risk of hypertension in women. Am J Epidemiol 1999;150:80616.
182w. Lindberg E, Janson,C, Gislason,T, Svardsudd,K, Hetta,J, Boman,G. Snoring and
hypertension: a 10 year follow-up. Eur Respir J 1998; 11:884-9.
183w. Lugaresi E, Cirignotta F, Coccagna G, Piana C. Some epidemiological data on
snoring and cardiocirculatory disturbances. Sleep 1980;3:221-4.
21
184w. Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and
sleep-disordered breathing. Health outcomes. Am J Respir Crit Care Med
1995;152:717-20.
185w. Waller PC, Bhopal RS. Is snoring a cause of vascular disease? An epidemiological
review. Lancet 1989;1:143-6.
186w. Noda A, Nakata S, Koike Y, Miyata S, Kitaichi K, Nishizawa T et al. Continuous
positive airway pressure improves daytime baroreflex sensitivity and nitric oxide
production in patients with moderate to severe obstructive sleep apnea syndrome.
Hypertens Res 2007;30:669-676.
187w. Lombardi C, Parati G, Cortelli P, Provini F, Vetrugno R, Plazzi G et al. Daytime
sleepiness and neural cardiac modulation in sleep-related breathing disorders. J
Sleep Res 2008;17:263-270.
188w. Chung F, Yegneswaran B, Liao P, Chung S, Vairavanathan S, Islam S et al. Validation
of the Berlin Questionnaire and American Society of Anesthesiologists Checklist as
Screening Tools for Obstructive Sleep Apnea in Surgical Patients. Anesthesiology
2008;108:822-830.
189w. Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S et al. Night-time and
diastolic hypertension are common and underestimated conditions in newly
diagnosed apnoeic patients J Hypertens. 2005;23:521-527.
190w. Wolf J, Hering D, Narkiewicz K. Non-dipping pattern of hypertension and
obstructive sleep apnea syndrome. Hypertens Res 2010;33:867-871.
191w. Lavie-Nevo K, Pillar G. Evening-morning differences in blood pressure in sleep
apnea syndrome: effect of gender. Am J Hypertens 2006;19:1064-1069.
192w. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood
pressure and heart rate variabilities in normotensive and hypertensive human
beings. Circ Res 1983;53:96-104.
22
193w. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour
blood pressure mean and variability to severity of target-organ damage in
hypertension. J hypertens 1987;5:93-8.
194w. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour
blood pressure variability. J Hypertens 1993;11:1133-1137.
195w. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Maronati A, Kawecka-Jaszcz K et al. A
new method for assessing 24-h blood pressure variability after excluding the
contribution of nocturnal blood pressure fall. J Hypertens 2007;25:2058-66.
196w. Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index
for the prognostic significance of blood pressure variability. J Hypertens
2005;23:505-11.
197w. Parati G, Faini A, Valentini M. Blood pressure variability: its measurement and
significance in hypertension. Curr Hypertens Rep 2006;8:199-204.
198w. Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P et al.
Relationship between short-term blood pressure variability and large-artery
stiffness in human hypertension: findings from 2 large databases. Hypertension
2012;60:369-77.
199w. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al. Relation
between blood pressure variability and carotid artery damage in hypertension:
baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J
Hypertens 2001;19:1981-9.
200w. Mancia G, Parati G. The role of blood pressure variability in end-organ damage. J
Hypertens Suppl 2003;21:S17-23.
201w. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G et al. Awake systolic
blood pressure variability correlates with target-organ damage in hypertensive
subjects. Hypertension 2007;50:325-32.
23
202w. Manios E, Tsagalis G, Tsivgoulis G, Barlas G, Koroboki E, Michas F, et al. Time rate
of blood pressure variation is associated with impaired renal function in
hypertensive patients. J Hypertens 2009;27:2244-8.
203w. Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF. Which parameters
of beat-to-beat blood pressure and variability best predict early outcome after
acute ischemic stroke? Stroke 2000;31:463-8.
204w. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M et al. Morning
surge in blood pressure as a predictor of silent and clinical cerebrovascular disease
in elderly hypertensives: a prospective study. Circulation 2003;107:1401-1406.
205w. Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood
pressure variability on cardiac and cerebrovascular complications in hypertension.
Am J Hypertens 2007;20:154-61.
206w. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M et al.
Prognostic significance of blood pressure and heart rate variabilities: the Ohasama
study. Hypertension 2000;36:901-906.
207w. Manios E, Stamatelopoulos K, Tsivgoulis G, Barlas G, Koroboki E, Tsagalis G et al.
Time rate of blood pressure variation: a new factor associated with coronary
atherosclerosis. J Hypertens 2011;29:1109-14.
208w. Liu JG, Xu LP, Chu ZX, Miao CY, Su DF. Contribution of blood pressure variability to
the effect of nitrendipine on end-organ damage in spontaneously hypertensive
rats. J Hypertens 2003;21:1961.
209w. Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH.
Circadian rhythms in blood pressure regulation and optimization of hypertension
treatment with ACE inhibitor and ARB medications. Am J Hypertens 2011;24:38391.
24
210w. Hermida RC, Diana E, Ayala DE, Mojón A, Fernández JR. Bedtime dosing of
antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol
2011;22:2313–2321.
211w. Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, et al. Changing
the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD:
an 8-week uncontrolled trial. Am J Kidney Dis 2007;50:908-17.
212w. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability,
carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study
on Atherosclerosis. Circulation. 2012;126:569-78.
213w. Mallion JM, Baguet JP, Siché JP, Tremel F, De Gaudemaris R. Clinical value of ABPM
monitoring. J Hypertens 1999;17:585–595.
214w. White W. Guidelines on the clinical utility of ABPM. Blood Press Monit 1998;3:181184.
215w. Asmar R, Lacourciere Y, on behalf of the Candesartan Cilexetil in Hypertension
Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators. A new
approach to assessing antihypertensive therapy: effect of treatment on pulse
pressure. J Hypertens 2000;18:1683–1690.
216w. Parati G, Ravogli A, Mutti E, Santucciu C, Omboni S, Mancia G. Ambulatory blood
pressure monitoring in the evaluation of antihypertensive drugs. J Hypertens
1994;12 (suppl 8):S9–S15.
217w. Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough-to-peak ratio of
antihypertensive treatment from ambulatory blood pressure: methodological
aspects. J Hypertens 1995;13:1105–1112.
218w. Moser M, Setaro JF. Resistant or difficult-to-control hypertension. N Engl J Med
2006;355:385-392.
25
219w. Oikawa T, Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H et al.; J-HOME Study
Group. Characteristics of resistant hypertension determined by self-measured
blood pressure at home and office blood pressure measurements: the J-HOME
study. J Hypertens 2006;24:1737-1743.
220w. Parker MG. Resistant hypertension: Core Curriculum 2008. Am J Kidney Dis
2008;52:796-802.
221w. Bunker J, Callister W, Chang CL, Sever PS. How common is true resistant
hypertension? J Hum Hypertens 2011;25:137-40.
222w. Nasothimiou EG, Tzamouranis D, Roussias LG, Stergiou GS. Home versus
ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true
resistant hypertension. J Hum Hypertens. 2012;26:696-700.
223w. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and
clinically overt stroke in older Japanese subjects with white coat and sustained
hypertension. J Am Coll Cardiol 2001;38:238–245.
224w. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24h ambulatory blood pressure characteristics for cardiovascular morbidity in a
population of elderly men. J Hypertens 2004;22:1691-1697.
225w. Eto M, Toba K, Akishita M, Kozaki K, Watanabe T, Kim S, Hashimoto M, Ako J, Iijima
K, Sudoh N, Yoshizumi M, Ouchi Y. Impact of blood pressure variability on
cardiovascular events in elderly patients with hypertension. Hypertens Res
2005;28:1-7.
226w. Palmas W, Pickering TG, Teresi J, Schwartz JE, Moran A, Weinstock RS, Shea S.
Ambulatory blood pressure monitoring and all-cause mortality in elderly people
with diabetes mellitus. Hypertension 2009;53:120-127.
26
227w. Ungar A, Pepe G, Lambertucci L, Fedeli A, Monami M, Mannucci E et al. Low
diastolic ambulatory blood pressure is associated with greater all-cause mortality
in older patients with hypertension. J Am Geriatr Soc 2009;57:291-296.
228w. Kario K, Ishikawa J, Eguchi K, Morinari M, Hoshide S, Ishikawa S, Shimada K. Sleep
pulse pressure and awake mean pressure as independent predictors for stroke in
older hypertensive patients. Am J Hypertens 2004;17:439-445.
229w. Kabutoya T, Hoshide S, Ishikawa J, Eguchi K, Shimada K, Kario K. The effect of pulse
rate and blood pressure dipping status on the risk of stroke and cardiovascular
disease in Japanese hypertensive patients. Am J Hypertens 2010;23:749-755.
230w. Blackwell T, Yaffe K, Ancoli-Israel S, Redline S, Ensrud KE, Stefanick ML et al.;
Osteoporotic Fractures in Men Study Group. Associations between sleep
architecture and sleep-disordered breathing and cognition in older communitydwelling men: the Osteoporotic Fractures in Men Sleep Study. J Am Geriatr Soc
2011:59:2217-25.
231w. Watanabe N, Imai Y, Nagai K, Tsuji I, Satoh H, Sakuma M et al. Nocturnal blood
pressure and silent cerebrovascular lesions in elderly Japanese. Stroke
1996;27:1319-1327.
232w. Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, Shimada K. Ucurve relationship between orthostatic blood pressure change and silent
cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a
new cardiovascular risk factor. J Am Coll Cardiol 2002;40:133-141.
233w. Kario K. Morning surge in blood pressure and cardiovascular risk: evidence and
perspectives. Hypertension 2010;56:765-773.
234w. Lurbe E, Redon J, Liao Y, Tacons J, Cooper RS, Alvarez V. Ambulatory blood
pressure monitoring in normotensive children. J Hypertens 1994;12:1417-1423.
27
235w. Brown MA, Mangos G, Davis G, Homer C. The natural history of white coat
hypertension during pregnancy. BJOG 2005;112:601-6.
236w. Churchill D, Perry IJ, Beevers DG. Ambulatory blood pressure in pregnancy and
fetal growth. Lancet 1997;349:7-10.
237w. Halligan AW, Shennan A, Lambert PC, Bell SC, Taylor DJ, de Swiet M. Automated
blood pressure measurement as a predictor of proteinuric pre-eclampsia. Br J
Obstet Gynaecol 1997;104:559-62.
238w. Feldman DM. Blood pressure monitoring during pregnancy. Blood Press Monit
2001;6:1-7.
239w. Liro M, Gasowski J, Wydra D, Grodzicki T, Emerich J, Narkiewicz K. Twenty-fourhour and conventional blood pressure components and risk of preterm delivery or
neonatal complications in gestational hypertension. Blood Press 2009;18:36-43.
240w. Waugh JJ, Halligan AW, Shennan AH. Ambulatory monitoring and self-monitoring
of blood pressure during pregnancy. Blood Press Monit 2000;5:3-10.
241w. Lowe SA, Brown MA, Dekker GA, Gatt S, McLintock CK, McMahon LP et al.; Society
of Obstetric Medicine of Australia and New Zealand. Guidelines for the
management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet
Gynaecol 2009;49:242-6.
242w. Walker SP, Higgins JR, Brennecke SP. Ambulatory blood pressure monitoring in
pregnancy. Obstet Gynecol Surv 1998;53:636-44.
243w. Borel AL, Benhamou PY, Baguet JP, Debaty I, Levy P, Pépin JL, Mallion JM. Short
sleep duration is associated with a blood pressure nondipping pattern in type 1
diabetes: the DIAPASOM study. Diabetes Care 2009;39:713-1715.
244w. Cuspidi C, Meani S, Lonati L, Fusi V, Valerio C, Sala C et al. Short-term
reproducibility of a nondipping pattern in type 2 diabetic hypertensive patients. J
Hypertens 2006;24:647–653.
28
245w. Nielsen FS, Gaede P, Vedel P, Pedersen O, Parving HH. White coat hypertension in
NIDDM patients with and without incipient and overt diabetic nephropathy.
Diabetes Care 1997;20:859-63.
246w. Marchesi C, Maresca AM, Solbiati F, Franzetti I, Laurita E, Nicolini E et al. Masked
hypertension in type 2 diabetes mellitus. Relationship with left-ventricular
structure and function. Am J Hypertens 2007;20:1079-84.
247w. Eguchi K, Ishikawa J, Hoshide S, Pickering TG, Shimada K, Kario K. Masked
hypertension in diabetes mellitus: a potential risk. J Clin Hypertens (Greenwich)
2007;9:601-7.
248w. Leitão CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL. Masked
hypertension, urinary albumin excretion rate, and echocardiographic parameters
in putatively normotensive type 2 diabetic patients. Diabetes Care 2007;30:125560.
249w. Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping
diurnal blood pressure and renal impairment are associated with increased
mortality in diabetes mellitus. Diabet Med 2000;17:360-364.
250w. Benhamou PY, Halimi S, De Gaudemaris R, Boizel R, Pitiot M, Siche JP et al. Early
disturbances of ambulatory blood pressure load in normotensive type I diabetic
patients with microalbuminuria. Diabetes Care 1992;15:1614-9.
251w. Ozawa M, Tamura K, Iwatsubo K, Matsushita K, Sakai M, Tsurumi-Ikeya Y et al.
Ambulatory blood pressure variability is increased in diabetic hypertensives. Clin
Exp Hypertens 2008;30:213-24.
252w. Sasaki E, Kitaoka H, Ohsawa N. Postprandial hypotension in patients with noninsulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1992;18:113-21.
253w. Palmas W, Pickering T, Eimicke JP, Moran A, Teresi J, Schwartz JE et al. Value of
ambulatory arterial stiffness index and 24-h pulse pressure to predict progression
29
of albuminuria in elderly people with diabetes mellitus. Am J Hypertens
2007;20:493-500.
254w. Czupryniak L, Pawłowski M, Saryusz-Wolska M, Loba J. Circadian blood pressure
variation and antihypertensive medication adjustment in normoalbuminuric type 2
diabetes patients. Kidney Blood Press Res 2007;30:182-6.
255w. Anan F, Masaki T, Fukunaga N, Teshima Y, Iwao T, Kaneda K et al. Pioglitazone shift
circadian rhythm of blood pressure from non-dipper to dipper type in type 2
diabetes mellitus. Eur J Clin Invest 2007;37:709-14.
256w. Komajda M, Curtis P, Hanefeld M, Beck-Nielsen H, Pocock SJ, Zambanini A et al.,
Record Study Group FT. Effect of the addition of rosiglitazone to metformin or
sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory
blood pressure in people with type 2 diabetes: a randomized controlled trial (the
RECORD study). Cardiovasc Diabetol 2008;7:10.
257w. de Rivas B, Luque M, Martell N, Fernández C, Fernández-Cruz A. Pioglitazone
decreases ambulatory blood pressure in type 2 diabetics with difficult-to-control
hypertension. J Clin Hypertens (Greenwich) 2007;9:530-7.
258w. Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos
CI et al. Ambulatory blood pressure reduction after rosiglitazone treatment in
patients with type 2 diabetes and hypertension correlates with insulin sensitivity
increase. J Hypertens 2004;22:1769-77.
259w. Nilsson PM, Hedblad B, Donaldson J, Berglund G. Rosiglitazone reduces office and
diastolic ambulatory blood pressure following 1-year treatment in non-diabetic
subjects with insulin resistance. Blood Press 2007;16:95-100.
260w. Bennett SM, Agrawal A, Elasha H, Heise M, Jones NP, Walker M, Wilding JP.
Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood
pressure in subjects with impaired glucose tolerance. Diabet Med 2004;21:415-22.
30
261w. Nakano S, Uchida K, Kigoshi T, Azukizawa S, Iwasaki R, Kaneko M, Morimoto S.
Circadian rhythm of blood pressure in normotensive NIDDM subjects. Its
relationship to microvascular complications. Diabetes Care 1991;14:707-711.
262w. Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M et al. Reversed circadian
blood pressure rhythm is associated with occurrences of both fatal and nonfatal
vascular events in NIDDM subjects. Diabetes 1998;47:1501-1506.
263w. Nakano S, Ito T, Furuya K, Tsuda S, Konishi K, Nishizawa M et al. Ambulatory blood
pressure level rather than dipper/nondipper status predicts vascular events in type
2 diabetic subjects. Hypertens Res 2004;27:647-656.
264w. Van Ittersum FJ, Wijering RM, Lambert J, Donker AJ, Stehouwer CD. Determinants
of the limits of agreement between the sphygmomanometer and the SpaceLabs
90207 device for blood pressure measurement in health volunteers and insulindependent diabetic patients. J Hypertens 1998;16:1125-30.
265w. Castilla-Guerra L, Fernández-Moreno Mdel C, Espino-Montoro A, López-Chozas JM.
Ambulatory blood pressure monitoring in stroke survivors: do we really control our
patients? Eur J Intern Med 2009;20:760-3.
266w. Vemmos KN, Tsivgoulis G, Spengos K, Synetos A, Manios E, Vassilopoulou S et al.
Blood pressure course in acute ischaemic stroke in relation to stroke subtype.
Blood Press Monit 2004;9:107-14.
267w. Lip GY, Zarifis J, Farooqi IS, Page A, Sagar G, Beevers DG. Ambulatory blood
pressure monitoring in acute stroke. The West Birmingham Stroke Project. Stroke
1997;28:31-5.
268w. de la Sierra A, Banegas JR, Segura J, Gorostidi M, Ruilope LM; CARDIORISC Event
Investigators. Ambulatory blood pressure monitoring and development of
cardiovascular events in high-risk patients included in the Spanish ABPM registry:
the CARDIORISC Event study. J Hypertens 2012;30:713-9.
31
269w. Toghi H, Chiba K, Kimura M. Twenty-four-hour variation of blood pressure in
vascular dementia of Binswanger type. Stroke 1991;7:477–483.
270w. Lee KW, Blann AD, Lip GY. High pulse pressure and nondipping circadian blood
pressure in patients with coronary artery disease: Relationship to thrombogenesis
and endothelial damage/dysfunction. Am J Hypertens 2005;18:104-15.
271w. Farmer CK, Goldsmith DJ, Cox J, Dallyn P, Kingswood JC, Sharpstone P. An
investigation of the effect of advancing uraemia, renal replacement therapy and
renal transplantation on blood pressure diurnal variability. Nephrol Dial Transplant
1997;12:2301-7.
272w. Lacson E, Jr., Lazarus JM. The association between blood pressure and mortality in
ESRD-not different from the general population? Semin Dial 2007;20:510-7.
273w. Agarwal R, Andersen MJ. Blood pressure recordings within and outside the clinic
and cardiovascular events in chronic kidney disease. Am J Nephrol 2006;26:503-10.
274w. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ et al. Nocturnal blood
pressure and 24-hour pulse pressure are potent indicators of mortality in
hemodialysis patients. Kidney Int 2000;57:2485-91.
275w. Agarwal R. Volume-associated ambulatory blood pressure patterns in hemodialysis
patients. Hypertension 2009;54:241-7.
276w. Hermida RC, Calvo C, Ayala DE, Lopez JE. Decrease in urinary albumin excretion
associated with the normalization of nocturnal blood pressure in hypertensive
subjects. Hypertension 2005;46:960-8.
277w. Agarwal R, Andersen MJ. Correlates of systolic hypertension in patients with
chronic kidney disease. Hypertension 2005;46:514-20.
278w. Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, et al. Nocturnal
blood pressure is elevated with natriuresis and proteinuria as renal function
deteriorates in nephropathy. Kidney Int 2004;65:621-5.
32
279w. Jacob P, Hartung R, Bohlender J, Stein G. Utility of 24-h ambulatory blood pressure
measurement in a routine clinical setting of patients with chronic renal disease. J
Hum Hypertens 2004;18:745-51.
280w. Csiky B, Kovacs T, Wagner L, Vass T, Nagy J. Ambulatory blood pressure monitoring
and progression in patients with IgA nephropathy. Nephrol Dial Transplant
1999;14:86-90.
281w. Knudsen ST, Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL. Ambulatory
pulse pressure, decreased nocturnal blood pressure reduction and progression of
nephropathy in type 2 diabetic patients. Diabetologia 2009;52:698-704.
282w. Iida T, Kohno I, Fujioka D, Ichigi Y, Kawabata K, Obata JE et al. Blunted reduction of
pulse pressure during nighttime is associated with left ventricular hypertrophy in
elderly hypertensive patients. Hypertens Res 2004;27:573-9.
283w. Owens P, O’Brien ET. Hypotension in patients with coronary disease – can
profound hypotensive events cause myocardial ischaemic events? Heart
1999;82:477–481.
284w. Viscomi P, Jeffrey J. Development of clinical practice guidelines for patient
management of blood pressure instability in multiple system atrophy, Parkinson's
disease, and other neurological disorders. Can J Neurosci Nurs 2010;32:6-19.
285w. Ejaz AA, Sekhon IS, Munjal S. Characteristic findings on 24-h ambulatory blood
pressure monitoring in a series of patients with Parkinson's disease. Eur J Intern
Med 2006;17:417-20.
286w. Loew F, Gauthey L, Koerffy A, Herrmann FR, Estade M, Michel JP, Vallotton MB.
Postprandial hypotension and orthostatic blood pressure responses in elderly
Parkinson's disease patients. J Hypertens 1995;13:1291-7.
33
287w. Plaschke M, Trenkwalder P, Dahlheim H, Lechner C, Trenkwalder C. Twenty-fourhour blood pressure profile and blood pressure responses to head-up tilt tests in
Parkinson's disease and multiple system atrophy. J Hypertens 1998;16:1433-41.
288w. Middeke M, Schrader J. Nocturnal blood pressure in normotensive subjects and
those with white coat, primary, and secondary hypertension. BMJ 1994;308:630632.
289w. Imai Y, Abe K, Sasaki S, Minami N, Munakata M, Nihei M et al. Exogenous
glucocorticoid eliminates or reverses circadian blood pressure variations. J
Hypertens 1989;7:113-120.
290w. Mansoor GA, White WB. Circadian blood pressure variation in hypertensive
patients with primary hyperaldosteronism. Hypertension 1998;31:843-847.
291w. Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A et al. Relation between
serum thyroid hormone and 'nondipper' circadian blood pressure variability.
Kidney Blood Press Res 2007;30:416-420.
292w. Kluglich M, Middeke M: [Circadian blood pressure rhythm in hyperthyroidism and
primary hyperparathyroidism]. Z Kardiol 1992;81 Suppl 2:33-36.
293w. Peters A, Gromeier S, Kohlmann T, Look D, Kerner W. Nocturnal blood pressure
elevation is related to adrenomedullary hyperactivity, but not to hyperinsulinemia,
in nonobese normoalbuminuric type 1 diabetes. J Clin Endocrinol Metab
1996;81:507-512.
294w. Meisel SR, Mor-Avi V, Rosenthal T, Akselrod S. Spectral analysis of the systolic
blood pressure signal in secondary hypertension: a method for the identification of
phaeochromocytoma. J Hypertens 1994;12:269-275.
295w. Dabrowska E, Lewandowski J, Jedrusik P, Symonides B, Wocial B, Lapinski M,
Gaciong Z. Catecholamine excretion and circadian blood pressure profile in
patients with pheochromocytoma. Ann N Y Acad Sci 2006;1073:79-85.
34
296w. Zelinka T, Strauch B, Petrak O, Holaj R, Vrankova A, Weisserova H et al. Increased
blood pressure variability in pheochromocytoma compared to essential
hypertension patients. J Hypertens 2005:23:2033-2039.
297w. Dabrowska B, Feltynowski T, Wocial B, Szpak W, Januszewicz W. Effect of removal
of phaeochromocytoma on diurnal variability of blood pressure, heart rhythm and
excretion of catecholamines. J Hum Hypertens 1990;4:397-399.
298w. Padfield PL, Stewart MJ. Ambulatory blood pressure monitoring in secondary
hypertension. J Hypertens Suppl 1991;9:S69-71.
299w. Colombo F, Catarame S, Cossovich P, Fundarò C, Perilli E, Fiorini T, Libretti A.
Isolated office hypertension: are there any markers of future blood pressure
status? Blood Press Monit 2000;5:249-54.
300w. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office
hypertension: a prehypertensive state? J Hypertens 1996;14:327–332.
301w. Polonia JJ, Gama JM, Silva JA, Amaral C, Martins LR, Bertoquini SE. Sequential
follow-up clinical and ambulatory blood pressure evaluation in a low risk
population of white-coat hypertensive patients and in normotensives. Blood Press
Monit 2005;10:57-64.
302w. Verdecchia P, Angeli F. The natural history of white-coat hypertension in the
longterm. Blood Press Monit 2005;10:65-66.
303w. Palatini P. Ambulatory and home blood pressure measurement: complementary
rather than competitive methods. Hypertension 2012;59:2-4.
304w. Hara A, Tanaka K, Ohkubo T, Kondo T, Kikuya M, Metoki H et al. Ambulatory versus
home versus clinic blood pressure: the association with subclinical cerebrovascular
diseases: the Ohasama Study. Hypertension 2012;59:22-28.
305w. Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG,
Mountokalakis TD. Reproducibility of home, ambulatory, and clinic blood pressure:
35
implications for the design of trials for the assessment of antihypertensive drug
efficacy. Am J Hypertens 2002;15:101-104.
306w. Hozawa A, Ohkubo T, Nagai K, Kikuya M, Matsubara M, Tsuji I et al. Prognosis of
isolated systolic and isolated diastolic hypertension as assessed by selfmeasurement of blood pressure at home: the Ohasama Study. Arch Intern Med
2000;160:3301–3306.
307w. Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J et al. Ohasama
Study. How many times should blood pressure be measured at home for better
prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J
Hypertens 2004;22:1099 –1104.
308w. Asayama K, Ohkubo T, Kikuya M, Metoki H, Obara T, Hoshi H et al. Use of 2003
European Society of Hypertension-European Society of Cardiology guidelines for
predicting stroke using self-measured blood pressure at home: the Ohasama
Study. Eur Heart J 2005;26:2026 –2031.
309w. Parati G, Pickering TG. Home blood-pressure monitoring: US and European
consensus. Lancet 2009;373:876–878.
310w. Mengden T, Binswanger B, Weisser B, Vetter W. An evaluation of self-measured
blood pressure in a study with a calcium-channel antagonist versus a beta-blocker.
Am J Hypertens 1992;5:154-60.
311w. Mengden T, Weisser B, Vetter W. Ambulatory 24-hour blood pressure versus selfmeasured blood pressure in pharmacologic trials. J Cardiovasc Pharmacol 1994;24
Suppl 2:S20-5.
312w. Mengden T, Bättig B, Schubert M, Jeck T, Weisser B, Buddeberg C, Vetter W.
Comparison of casual, ambulatory and self-measured blood pressure in a study of
nitrendipine vs bisoprolol. Eur J Clin Pharmacol. 1992;42:569-75.
36
313w. Mengden T, Uen S, Baulmann J, Vetter H. Significance of blood pressure selfmeasurement as compared with office blood pressure measurement and
ambulatory 24-hour blood pressure measurement in pharmacological studies.
Blood Press Monit 2003;8:169-72.
314w. Floras JS, Jones JV, Hassan MO, Sleight P. Ambulatory blood pressure during oncedaily randomised double-blind administration of atenolol, metoprolol, pindolol,
and slow-release propranolol. BMJ 1982;285:1387–92.
315w. Parati G, de Leeuw P, Illyes M, Julius S, Kuwajima I, Mallion JM, Ohtsuka K, Imai Y;
2001 Consensus Conference on Ambulatory Blood Pressure Monitoring
participants. Blood pressure measurement in research. Blood Press Monit. 2002
Feb;7(1):83-7.
316w. Oliver JJ, Dear JW, Webb DJ. Clinical potential of combined organic nitrate and
phosphodiesterase type 5 inhibitor in treatment-resistant hypertension.
Hypertension 2010;56:62-7.
317w. Geiger H, Barranco E, Gorostidi M et al. Combination therapy with various
combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive
patients not adequately responsive to hydrochlorothiazide alone. J Clin Hypertens
(Greenwich) 2009;11:324–32.
318w. Barrios V, Brommer P, Haag U, Calderon A, Escobar C. Olmesartan medoxomil plus
amlodipine increases efficacy inpatients with moderate-to-severe hypertension
after monotherapy. A randomized, double-blind, parallel-group, multicentre study.
Clin Drug Invest 2009;29:427–39.
319w. Rump LC, Girerd X, Sellin L, Stegbauer J. Effects of high dose olmesartan
medoxomil plus hydrochlorothiazide on blood pressure control in patients with
grade 2 and grade 3 hypertension. J Hum Hypertens 2011;25:565-74.
37
320w. Oparil S, Melino M, Lee J, Fernandez V, Heyrman R. Triple therapy with olmesartan
medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with
hypertension: The TRINITY multicenter, randomized, double-blind, 12-week,
parallel-group study. Clin Ther 2010;32:1252–69.
321w. Martinez-Martin FJ, Rodriguez-Rosas H, Peiro-Martinez I, Soriano-Perera P,
Pedrianes-Martin P, Comi-Diaz C. Olmesarta/amlodipine vs
olmesartan/hydrochlorothiazide in hypertensive patients with metabolic
syndrome: the OLAS study. J Hum Hypertens 2011;25:346-53.
322w. Chrysant SG, Lee J, Melino M, Karki S, Heyrman R. Efficacy and tolerability of
amlodipine plus olmesartan medoxomil in patients with difficult-to-treat
hypertension. J Hum Hypertens 2010;24:730–8.
323w. Chrysant SG, Murray AV, Hoppe UC, Dattani D, Patel S, Ritter S, Zhang J. Long-term
safety and efficacy of aliskiren and valsartan combination with or without the
addition of HCT in patients with hypertension. Curr Med Res Opin 2010;26:2841–9.
324w. Böhm M, Baumhäkel M, Mahfoud F, Werner C. From Evidence to Rationale:
Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with
Angiotensin-Converting Enzyme Inhibitors. Cardiology 2010;117:163–73.
325w. Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL et al.; AASK
Collaborative Research Group. Intensive blood-pressure control in hypertensive
chronic kidney disease. N Engl J Med 2010;363:918–29.
326w. Wright JT Jr, Lacourcière Y, Samuel R, Zappe D, Purkayastha D, Black HR. 24-Hour
ambulatory blood pressure response to combination
valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2
hypertension by ethnicity: the EVALUATE study. J Clin Hypertens (Greenwich)
2010;12:833-40.
38
327w. Lv Y, Zou Z, Chen G, Jia HX, Zhong J, Fang WW. Amlodipine and angiotensinconverting enzyme inhibitor combination versus amlodipine monotherapy in
hypertension: a meta-analysis of randomized controlled trials. Blood Press Monit
2010;15:195-204.
328w. Punzi H, Neutel JM, Kereiakes DJ, Shojaee A, Waverczak WF, Dubiel R, Maa JF.
Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension:
the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Ther Adv Cardiovasc Dis 2010;4:209–21.
329w. Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV et al. Divergent
results using clinic and ambulatory blood pressures. Report of a darusentan–
resistant hypertension trial Hypertension. 2010; 56:824–30.
330w. Parati G, Ochoa JE, Ramos C, Hoshide S, Lonati L, Bilo G. Efficacy and tolerability of
olmesartan/⁄amlodipine combination therapy in patients with mild-to-severe
hypertension: focus on 24-h blood pressure control. Ther Adv Cardiovasc Dis
2010;4:301–13.
331w. Eguchi K, Hoshide S, Kabutoya T, Shimada K, Kario K. Is very low dose
hydrochlorothiazide combined with candesartan effective in uncontrolled
hypertensive patients? Blood Press Monit 2010;15:308–11.
332w. Malacco E, Omboni S, Volpe M, Auteri A, Zanchetti A on behalf of the ESPORT
Study Group. Antihypertensive efficacy and safety of olmesartan medoxomil and
ramipril in elderly patients with mild to moderate essential hypertension: the
ESPORT study. J Hypertens 2010;28:2342–50.
333w. Ruilope LM, Dukat A, Böhm M, Lacourcière Y, Gong J, Lefkowitz MP. Bloodpressure reduction with LCZ696,a novel dual-acting inhibitor of the angiotensin II
receptor and neprilysin: a randomised, double-blind, placebo-controlled, active
comparator study. Lancet 2010;375:1255–66.
39
334w. Kabakci G, Kaya BE, Tulumen E, Kocabas U, Abali G, Deveci O et al. The efficacy and
safety of irbesartan in primary hypertension even if a dose is missed: results from
the NOPROBLEM Study. Blood Press 2010;1:5-9.
335w. Alvarez-Alvarez B, Abad-Cardie lM, Fernandez-Cruz S,Martell-Claros N.
Management of resistant arterial hypertension: role of spironolactone versus
double blockade of the renin–angiotensin–aldosterone system. J Hypertens
2010;28:2329–35.
336w. Stockbridge N. ABPM Part of FDA Reviews. Drug Information J 2011;45:567-568.
337w. Mancia G, Omboni S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma
RP.Twenty-four hour ambulatory blood pressure in the Hypertension Optimal
Treatment (HOT) study. J Hypertens 2001;19:1755-63.
338w. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of
ramipril on ambulatory and office blood pressures: a HOPE Substudy. Hypertension
2001;38:E28-32.
339w. Mancia G, Omboni S, Parati G; Investigators of the INSIGHT ABPM substudy.
Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS
Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens
2002;20:545-53.
340w. Pedersen OL, Mancia G, Pickering T, Høegholm A, Julius S, Kjeldsen SE et al.; VALUE
trial group. Ambulatory blood pressure monitoring after 1 year on valsartan or
amlodipine-based treatment: a VALUE substudy. J Hypertens 2007;25:707-12.
341w. Mancia G, Parati G, Bilo G, Gao P, Fagard R, Redon J et al. Ambulatory blood
pressure values in the Ongoing Telmisartan Alone and in Combination with
Ramipril Global Endpoint Trial (ONTARGET). Hypertension 2012;60:1400-6.
342w. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, de Leeuw PW,
Dobovisek J, Jääskivi M, Leonetti G, O'Brien E, Palatini P, Parati G, Rodicio JL,
40
Vanhanen H, Webster J. Response to antihypertensive therapy in older patients
with sustained and nonsustained systolic hypertension. Systolic Hypertension in
Europe (Syst-Eur) Trial Investigators. Circulation 2000;102:1139–1144.
343w. Persu A, Renkin J, Thijs L, Staessen JA. Renal denervation: ultima ratio or standard
in treatment-resistant hypertension. Hypertension 2012;60:596-606.
344w. http://www.priorityhealth.com/provider/manual/auths/~/media/documents/medi
cal-policies/91503.pdf
345w. http://www.aetna.com/cpb/medical/data/1_99/0025.html
346w. Lorgelly P, Siatis I, Brooks A, Slinn B, Millar-Craig MW, Donnelly R, Manning G. Is
ambulatory blood pressure monitoring cost-effective in the routine surveillance of
treated hypertensive patients in primary care? Br J Gen Prac 2003;53:794-796.
347w. Parati G, Ibsen H. Twenty-four-hour ambulatory blood pressure profiles of high-risk
patients in general practice: data from an ambulatory blood pressure monitoring
registry. J Hypertens 2007;25:929-933.
348w. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard
care with a physician and pharmacist team approach for uncontrolled
hypertension. J Gen Intern Med 1998;11:740-5.
349w. Borenstein JE, Graber G, Saltiel E, Wallace J, Ryu S, Archi J et al. Physicianpharmacist comanagement of hypertension: a randomized, comparative trial.
Pharmacotherapy 2003;23:209-16.
350w. Jones OW and Peterson EO. Improving hypertension control rates-technology,
people, or systems? JAMA 2008;299:2896-2898.
351w. Von Muenster SJ, Carter BL, Weber CA, Ernst ME, Milchak JL, Steffensmeier JJ, Xu
Y. Description of pharmacist interventions during physician-pharmacist comanagement of hypertension. Pharm World Sci 2008;30:128-35
41
352w. Guglielmo BJ. A prescription for improved chronic disease management: have
community pharmacists function at the top of their training: comment on
"Engaging physicians and pharmacists in providing smoking cessation counseling".
Arch Intern Med 2010;170:1646-7.
353w. Tobari H, Arimoto T, Shimojo N, Yuhara K, Noda H, Yamagishi K, Iso H. Physicianpharmacist cooperation program for blood pressure control in patients with
hypertension: a randomized-controlled trial. Am J Hypertens 2010;23:1144-52.
354w. Carter BL, Foppe van Mil JW. Comparative Effectiveness Research: Evaluating
Pharmacist Interventions and Strategies to Improve Medication Adherence. Am J
Hypertens 2010;23:949-55.
355w. O’Brien E. ABPM saves not only money but also lives. Ir Med Times 2011.10.14;52.
356w. CoreLab Partners: http://corelabpartners.com/Services/CardiovascularSafety/ABPM.aspx
357w. LifeLabs Medical Laboratory Services:
http://www.lifelabs.com/files/ABPM_10131398_V2_July_2012.pdf
358w. Dabl Ltd: http://www.dabl.ie/en/default.aspx
359w. Carditronics: http://cardiotronics.ca/en/whoweare.htm
360w. Integrium Cardiovascular Core Laboratory: http://www.centerwatch.com/newsresources/industry-providers/provider-details.aspx?ProviderID=512
361w. Cardioanalytics: http://cardioanalytics.com/pdf/ABP.pdf
362w. Larsson S, Lawyer P, Garellick G, Lindahl B, Lundström M. Use of 13 disease
registries in 5 countries demonstrates the potential to use outcome data to
improve health care's value. Health Aff (Millwood) 2012;31:220-7.
363w. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA et al. Reply to:
"Clinical thresholds for ambulatory blood pressure measurement reinvented?".
BMJ 2010;Rapid Response:14 May 2010. http://www.bmj.com/rapid-
42
response/2011/11/02/reply-%E2%80%9Cclinical-thresholds-ambulatory-bloodpressure-measurement-reinvente
364w. Sehestedt T, Hansen TW, Li Y, Richart T, Boggia J, Kikuya M et al. Are blood
pressure and diabetes additive or synergistic risk factors? Outcome in 8494
subjects randomly recruited from 10 populations. Hypertens Res 2011;34:714-21.
365w. Li Y, Thijs L, Hansen TW, Kikuya M, Boggia J, Richart T, Metoki H et al., for the
International Database on Ambulatory Blood Pressure Monitoring in Relation to
Cardiovascular Outcomes Investigators. Prognostic value of the morning blood
pressure surge in 5645 subjects from 8 populations. Hypertension 2010;55:10401048.
366w. Palatini P, Reboldi G, Beilin LJ, Eguchi K, Imai Y, Kario K et al. Predictive value of
night-time heart rate for cardiovascular events in hypertension. The ABPInternational study. Int J Cardiol. 2013 Feb 7. doi:pii: S0167-5273(13)00028-4.
43